Orlando Matthew, an insider at Kenvue Inc (KVUE), executed a sale of 38,075 shares on December 14, 2025, at a price of $17.21 per share, resulting in a total transaction value of $655,000. Following this transaction, he retains 38,075 shares in the company.
Kenvue Inc, a consumer health company headquartered in Summit, New Jersey, specializes in manufacturing and selling a diverse range of healthcare products, including well-known brands such as Tylenol, Neutrogena, Listerine, and Johnson’s. The company, which went public on May 4, 2023, boasts a market capitalization of $33.1 billion and operates across three segments: Self Care, Skin Health and Beauty, and Essential Health. The company’s P/E ratio stands at 23.10, with an EPS of 0.74 and a dividend yield of 480.3%.
Insider selling can occur for various reasons, including diversification and personal financial needs. While such transactions may raise questions among investors, they do not necessarily reflect negative sentiments about the company. It is crucial for investors to consider insider activity as part of a broader analysis, examining patterns across multiple insiders and time periods rather than isolated transactions.
Kenvue's upcoming earnings are scheduled for February 4, 2026, with an estimated EPS of $0.23 and revenue of $3.8 billion, followed by another report on May 6, 2026, with an estimated EPS of $0.26 and revenue of $3.9 billion. These figures provide additional context for evaluating the company's performance and insider activity.